title: Uterine serous and grade 3 endometrioid carcinomas: is there a survival difference?
authors.affiliation: Department of Obstetrics and Gynecology, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina 27599, USA.
authors.forename: David M
authors.initials: DM
authors.lastname: Boruta
authors.forename: Paola A
authors.initials: PA
authors.lastname: Gehrig
authors.forename: Pamela A
authors.initials: PA
authors.lastname: Groben
authors.forename: Victoria
authors.initials: V
authors.lastname: Bae-Jump
authors.forename: John F
authors.initials: JF
authors.lastname: Boggess
authors.forename: Wesley C
authors.initials: WC
authors.lastname: Fowler
authors.forename: Linda
authors.initials: L
authors.lastname: Van Le
mesh_terms: D018269:Carcinoma, Endometrioid / Q000401:mortality* / Q000473:pathology; D018284:Cystadenocarcinoma, Serous / Q000401:mortality* / Q000473:pathology; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D011379:Prognosis; D012189:Retrospective Studies; D014594:Uterine Neoplasms / Q000401:mortality* / Q000473:pathology